Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Change in Cash (2016 - 2017)

Tenax Therapeutics' Change in Cash history spans 8 years, with the latest figure at -$159073.0 for Q4 2017.

  • For Q4 2017, Change in Cash fell 101.72% year-over-year to -$159073.0; the TTM value through Dec 2017 reached -$8.4 million, down 232.45%, while the annual FY2025 figure was $2.7 million, 96.81% down from the prior year.
  • Change in Cash for Q4 2017 was -$159073.0 at Tenax Therapeutics, up from -$469803.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $52.0 million in Q2 2014 and bottomed at -$36.4 million in Q3 2014.
  • The 5-year median for Change in Cash is -$1.3 million (2016), against an average of -$126836.5.
  • The largest annual shift saw Change in Cash soared 305.48% in 2013 before it plummeted 1205.42% in 2014.
  • A 5-year view of Change in Cash shows it stood at -$1.5 million in 2013, then plummeted by 396.8% to -$7.6 million in 2014, then soared by 43.75% to -$4.3 million in 2015, then skyrocketed by 316.9% to $9.3 million in 2016, then crashed by 101.72% to -$159073.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Change in Cash are -$159073.0 (Q4 2017), -$469803.0 (Q3 2017), and -$4.8 million (Q2 2017).